All Monthly Communication Reports for MMV Medicines for Malaria Venture

Paul Moen, Earnscliffe Strategy Group Inc. (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-54 of 54


  1. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Peter Boehm, Senator | Senate of Canada

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2018-11-23
    Posted date: 2018-12-15
    Communication number: 337427-442556 View associated registration

  2. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Emily Yorke, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2018-11-22
    Posted date: 2018-12-15
    Communication number: 337427-442554 View associated registration

  3. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2018-11-22
    Posted date: 2018-12-15
    Communication number: 337427-442553 View associated registration

  4. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Kathleen Davis, Special Assistant, Global Support | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2018-11-22
    Posted date: 2018-12-15
    Communication number: 337427-442550 View associated registration

  5. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Hilary Travis, Special Assistant | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Research and Development
    Communication date: 2018-05-03
    Posted date: 2018-06-15
    Communication number: 337427-428851 View associated registration

  6. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Emily Yorke, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: International Development
    Communication date: 2018-04-18
    Posted date: 2018-05-15
    Communication number: 337427-426717 View associated registration

  7. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Kathleen Davis, Special Assistant | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2018-04-18
    Posted date: 2018-05-15
    Communication number: 337427-426715 View associated registration

  8. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Claude Thibault, Senior Policy Advisor | Global Affairs Canada (GAC)
    • Lara Pocock, Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Development
    Communication date: 2017-10-31
    Posted date: 2017-11-15
    Communication number: 337427-413616 View associated registration

  9. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Alexander Slusar, Policy Analyst | Veterans Affairs Canada (VAC)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403764 View associated registration

  10. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Paul McCarthy, Director of Policy | Veterans Affairs Canada (VAC)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403763 View associated registration

  11. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Kent Hehr, Minister | Veterans Affairs Canada (VAC)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403762 View associated registration

  12. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Stephanie Delorme, Stakeholder Relations Advisor | House of Commons

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403757 View associated registration

  13. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Andrea Faubert, Policy Advisor | House of Commons

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403755 View associated registration

  14. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Javid Dharas, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403189 (amended from 337427-403133) View associated registration

  15. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Celina Caesar-Chavannes, Parliamentary Secretary to the Minister of International Development | House of Commons

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403184 View associated registration

  16. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Pierre-Yves Bourque, Legislative Assistant | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403156 View associated registration

  17. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Hana Button, Director of Policy | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403153 View associated registration

  18. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Lara Pocock, Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403148 View associated registration

  19. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Mobina Jaffer, Senator | Senate of Canada

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-17
    Posted date: 2017-06-15
    Communication number: 337427-403136 View associated registration

  20. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Kelvin Kenneth Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2017-05-16
    Posted date: 2017-06-15
    Communication number: 337427-403130 View associated registration

  21. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Christina Rettig, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-11-29
    Posted date: 2016-12-15
    Communication number: 337427-390914 View associated registration

  22. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Christina Rettig, Policy Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-11-29
    Posted date: 2016-12-15
    Communication number: 337427-389667 View associated registration

  23. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Ian Foucher, Policy Advisor | Finance Canada (FIN)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-11-04
    Posted date: 2016-12-15
    Communication number: 337427-390920 View associated registration

  24. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Peter Boehm, Deputy Minister of International Development | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-11-04
    Posted date: 2016-12-15
    Communication number: 337427-390919 View associated registration

  25. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Russell Milon, Director of Parliamentary Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-11-04
    Posted date: 2016-12-15
    Communication number: 337427-390917 View associated registration

  26. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Tyler Meredith, Policy Advisor | Prime Minister's Office (PMO)
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)
    • Emmaline English, Special Assistant | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-11-04
    Posted date: 2016-12-15
    Communication number: 337427-390915 View associated registration

  27. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Hanna Button, Policy Advisor | Global Affairs Canada (GAC)

    Subject Matter of the communication: Health, International Development
    Communication date: 2016-08-15
    Posted date: 2016-09-15
    Communication number: 337427-383149 View associated registration

  28. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Marc Miller, Member of Parliament | House of Commons

    Subject Matter of the communication: International Development
    Communication date: 2016-06-14
    Posted date: 2016-07-15
    Communication number: 337427-381377 View associated registration

  29. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Russell Milon, Director of Parliamentary Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Development
    Communication date: 2016-06-08
    Posted date: 2016-07-15
    Communication number: 337427-379478 View associated registration

  30. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Peter Boehm, Deputy Minister | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Development
    Communication date: 2016-05-19
    Posted date: 2016-06-15
    Communication number: 337427-379477 View associated registration

  31. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Karina Gould, MP, Parliamentary Secretary to the Minister of International Development | House of Commons

    Subject Matter of the communication: International Development
    Communication date: 2016-03-08
    Posted date: 2016-07-20
    Communication number: 337427-381768 (amended from 337427-374121) View associated registration

  32. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Russell Milon, Director of Parliamentary Affairs | Global Affairs Canada (GAC)

    Subject Matter of the communication: International Development
    Communication date: 2016-03-08
    Posted date: 2016-04-15
    Communication number: 337427-374131 View associated registration

  33. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Kelvin Kenneth Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2016-03-08
    Posted date: 2016-04-15
    Communication number: 337427-374128 View associated registration

  34. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Mathieu Bouchard, Senior Advisor | Prime Minister's Office (PMO)

    Subject Matter of the communication: Health, International Development, Research and Development
    Communication date: 2016-03-08
    Posted date: 2016-04-15
    Communication number: 337427-374125 View associated registration

  35. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Mobina Jaffer, Senator | Senate of Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-11-03
    Posted date: 2015-12-15
    Communication number: 337427-365104 View associated registration

  36. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Paul Calandra, Parliamentary Secretary | House of Commons

    Subject Matter of the communication: International Development
    Communication date: 2015-05-28
    Posted date: 2015-06-15
    Communication number: 337427-356247 View associated registration

  37. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Parliamentary Secretary | House of Commons
    • Michael Patton, Policy Advisor | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-05-27
    Posted date: 2015-06-15
    Communication number: 337427-356249 View associated registration

  38. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Salma Ataullahjan, Senator | Senate of Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-05-27
    Posted date: 2015-06-15
    Communication number: 337427-356248 View associated registration

  39. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Michelle Rempel, Minister of State (Western Economic Diversification) | Western Economic Diversification Canada (WD)

    Subject Matter of the communication: International Development
    Communication date: 2015-05-27
    Posted date: 2015-06-15
    Communication number: 337427-356246 View associated registration

  40. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Candice Baetz, Policy Advisor | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-05-27
    Posted date: 2015-06-15
    Communication number: 337427-356242 View associated registration

  41. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Lynn Yelich, Minister of State (Foreign Affairs & Consular) | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-05-27
    Posted date: 2015-06-15
    Communication number: 337427-356241 View associated registration

  42. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Kelvin Ogilvie, Senator | Senate of Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-05-27
    Posted date: 2015-06-15
    Communication number: 337427-356239 View associated registration

  43. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Joyce Seto, Senior Analyst Health and Nutrition Bureau | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2015-03-25
    Posted date: 2015-04-15
    Communication number: 337427-351563 View associated registration

  44. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Amy Day, Parliamentary Secretary's Assistant | Prime Minister's Office (PMO)

    Subject Matter of the communication: International Development
    Communication date: 2015-03-20
    Posted date: 2015-04-15
    Communication number: 337427-351559 View associated registration

  45. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Eric Madueno, Acting Chief | Finance Canada (FIN)

    Subject Matter of the communication: International Development
    Communication date: 2015-02-17
    Posted date: 2015-03-16
    Communication number: 337427-349015 View associated registration

  46. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Amy Day, Parliamentary Secretary's Assistant | Prime Minister's Office (PMO)

    Subject Matter of the communication: International Development
    Communication date: 2014-11-19
    Posted date: 2014-12-15
    Communication number: 337427-341558 View associated registration

  47. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Patricia Pena, Director General | Foreign Affairs, Trade and Development Canada
    • Andrew Dawe, Deputy Director | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2014-11-19
    Posted date: 2014-12-15
    Communication number: 337427-341556 View associated registration

  48. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Salma Ataullahjan, Senator | Senate of Canada

    Subject Matter of the communication: International Development
    Communication date: 2014-11-05
    Posted date: 2014-12-15
    Communication number: 337427-341555 View associated registration

  49. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Paul Calandra, Member of Parliament | House of Commons

    Subject Matter of the communication: International Development
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 337427-341553 View associated registration

  50. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Lois Brown, Member of Parliament | House of Commons

    Subject Matter of the communication: International Development
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 337427-341551 View associated registration

  51. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Julia Calder, Senior Development Officer | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 337427-341549 View associated registration

  52. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Ashraf Hassanein, Development Officer | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 337427-341548 View associated registration

  53. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Chris MacLennan, Director General | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2014-11-04
    Posted date: 2014-12-15
    Communication number: 337427-341545 View associated registration

  54. MMV Medicines for Malaria Venture
    Consultant: Paul Moen
    Designated Public Office Holders who participated in the communication:
    • Ashraf Hassanein, Development Officer | Foreign Affairs, Trade and Development Canada
    • May Wong, Deputy Director | Foreign Affairs, Trade and Development Canada
    • Monique Bergeron, Deputy Director | Foreign Affairs, Trade and Development Canada
    • Tommie Eugene Roberts, Senior Development Officer | Foreign Affairs, Trade and Development Canada
    • Stephen Sandiford, Development Officer | Foreign Affairs, Trade and Development Canada
    • Chantal Labelle, Director | Foreign Affairs, Trade and Development Canada

    Subject Matter of the communication: International Development
    Communication date: 2014-10-22
    Posted date: 2014-11-12
    Communication number: 337427-337995 View associated registration



Return to MMV Medicines for Malaria Venture